FDA Inspection 1029792 — Vitalant

Vitalant — FEI 3011010065

The FDA completed an inspection of Vitalant on Oct 3, 2017 in Granite Bay, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Oct 3, 2017
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Granite Bay, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.